Article
A 23-gene multi-omics signature predicts prognosis and treatment response in non-small cell lung cancer
23 Jul 2025
Abstract excerpt
BACKGROUND: We developed the first multi-omics prognostic signature integrating 19 programmed cell death (PCD) pathways and organelle functions (mitochondria, lysosomes, Golgi apparatus) to predict prognosis and immunotherapy response in non-small cell lung cancer (NSCLC). (2) Methods: By combining single-cell RNA-seq, bulk transcriptomics, and deep neural networks (DNN), we identified a 23-gene signature...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
